TI histograms of normal-appearing brain tissue are abnormal in early relapsing-remitting multiple sclerosis

Griffin, C.M.; Dehmeshki, J.; Chard, D.T.; Parker, G.J.M.; Thompson, A.J.; Miller, D.H.
May 2002
Multiple Sclerosis (13524585);May2002, Vol. 8 Issue 3, p211
Academic Journal
Discusses a study which investigated abnormalities in early relapsing-remitting multiple sclerosis. Information on the study population; Protocol for applying magnetic resonance imaging; Identification of lesion on thoracic nerve; Results and discussion.


Related Articles

  • Neutralizing antibodies and interferon treatment of multiple sclerosis: addressing the open questions. Oger, J. // Multiple Sclerosis (13524585);May2007 Supplement 1, Vol. 13, pS5 

    The article discusses the significance of neutralizing antibodies (NAbs) and interferon on the treatment for multiple sclerosis (MS). The interferon beta therapies signified clear disease-modifying activity in MS that reduced relapse rate and magnetic resonance imaging disease burden. It is...

  • Paradoxically aggressive multiple sclerosis In the face of natalizumab therapy. Berger, J. R. // Multiple Sclerosis (13524585);Jun2008, Vol. 14 Issue 5, p708 

    In the pivotal trials of natalizumab in the treatment of relapsing-remitting multiple sclerosis (AFFIRM and SENTINEL), a dramatic reduction in relapse rate, new or enlarging T2-hyperintense lesions, and mean number of gadolinium-enhancing lesions was observed. While both relapses and new MRI...

  • Diffusion tensor imaging of early relapsing-remitting multiple sclerosis with histogram analysis using automated segmentation and brain volume correction. Rashid, W.; Hadjiprocopis, A.; Griffin, C. M.; Chard, D. T.; Davies, G. R.; Barker, G. J.; Tofts, P. S.; Thompson, A. J.; Miller, D. H. // Multiple Sclerosis (13524585);Feb2004, Vol. 10 Issue 1, p9 

    Diffusion tensor magnetic resonance imaging (DTI) reveals measurable abnormalities in normal-appearing brain tissue (NABT) in established multiple sclerosis (MS). However, it is unclear how early this occurs. Recent studies have employed whole brain histogram analysis to improve sensitivity, but...

  • Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis. Prosperini, Luca; Giannì, Costanza; Leonardi, Laura; De Giglio, Laura; Borriello, Giovanna; Galgani, Simonetta; Pozzilli, Carlo; Gasperini, Claudio // Multiple Sclerosis Journal;Jan2012, Vol. 18 Issue 1, p64 

    Objective: To evaluate whether an escalation approach was more effective in suppressing clinical and magnetic resonance imaging (MRI) activity than switching among immunomodulators in relapsing–remitting multiple sclerosis (RRMS) patients.Methods: In this post-marketing, prospective,...

  • Benign multiple sclerosis in Crete. Mastorodemos, V.; Nikolakaki, H.; Tzagournissakis, M.; Kotzamani, D.; Panou, T.; Spanak, C.; Klados, G.; Maris, T.; Kontolaimaki, E.; Psaroudaki, K.; Chlouverakis, G.; Georgakakis, G.; Plaitakis, A. // Multiple Sclerosis (13524585);Jun2010, Vol. 16 Issue 6, p701 

    Our objective was to study multiple sclerosis on Crete, an island of 0.6 million inhabitants sharing a similar genetic background and the same environment. Case ascertainment was achieved using the MS Epidemiology Program Project of Crete. The diagnosis and classification of multiple sclerosis...

  • Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Løken-Amsrud, Kristin I; Myhr, Kjell-Morten; Bakke, Søren J; Beiske, Antonie G; Bjerve, Kristian S; Bjørnarå, Bård T; Hovdal, Harald; Lilleås, Finn; Midgard, Rune; Pedersen, Tom; Benth, Jūratė Šaltytė; Torkildsen, Øivind; Wergeland, Stig; Holmøy, Trygve // Multiple Sclerosis Journal;Apr2013, Vol. 19 Issue 4, p451 

    The article presents a study which investigates the association of disease activity and retinol in multiple sclerosis (MS). The study repeatedly assessed the magnetic resonance imaging (MRI) and serum-retinol. The result of the study shows that serum retinol was inversely linked with subsequent...

  • What is the Course of MS?  // Multiple Sclerosis: Hope through Research (NINDS);May2010, p9 

    The article presents a discussion on the course of manifestation of multiple sclerosis (MS). MS initially shows as a series of attacks followed by complete or partial remissions as symptoms lessen and return only later, which is called relapsing-remitting MS. 20 percent of MS patients have a...

  • POI03 Using natalizumab in highly active relapsing remitting multiple sclerosis in the UK. R Nicholas // Journal of Neurology, Neurosurgery & Psychiatry;Nov2010, Vol. 81 Issue 11, pe53 

    INTRODUCTION: Natalizumab is licenced in the UK for highly active relapsing remitting multiple sclerosis (RRMS) which is in contrast to the original trials that only studied early RRMS. These original studies demonstrated a reduction in relapse rates of 82% after 1 year compared to the year...

  • Which MS Biomarkers Predict Disease Progression? Marshall, Adriene // Neurology Reviews;Dec2015, Vol. 23 Issue 12, p14 

    The article focuses on a study presented at the 31st Congress of the European Committee for Treatment and Research in multiple sclerosis which showed that magnetic resonance imaging (MRI) findings and Expanded Disability Status Scale (EDSS) score can help predict which patients will have...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics